Logo
Search

Rules:

Only words with 2 or more characters are accepted
Max 200 chars total
Space is used to split words, "" can be used to search for a whole string (not indexed search then)
AND, OR and NOT are prefix words, overruling the default operator
+/|/- equals AND, OR and NOT as operators.
All search words are converted to lowercase.

Search for "individual"

Displaying results 1 to 6 out of 6

  Services 81%
  ... Statistical Analysis (STAT), Medical Writing and Clinical Trial Supply Management (CTSM) support the clinical conduct according to the client’s individual needs. Over the past decades, the group has performed several hundreds of clinical trials, maintaining rigorous adherence to GCP-guidelines to ...
  Size: 30 K - Created: 18-11-12 - Modified: 28-06-17 16:13
Path: /Services

  CTSM & GMP 77%
  ... dosage forms (e.g. tablets, capsules, gels, cremes and solutions (oral & i.v.), TTS) as stated in the manufacturing license. Randomisation of individual trial packs, preparation of individual trial medication for Phase I – III studies (small sample sizes are also possible).   Our well trained staff dedicated to the GMP area is able ...
  Size: 33 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Services/CTSM & GMP

  Medical Writing 74%
  ... documents – and this is where the Medical Writing Team of CRS comes in. The Medical Writing Team offers expert services ranging from preparing individual documents to producing all the documents needed for the draw up, coordination and documentation of clinical trials in a scientifically accurate ...
  Size: 32 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Services/Medical Writing

  Early Phase I to IIa 72%
  Early Phase I to IIa Each clinical trial brings new challenges and has to be seen from an individual perspective. The staff of CRS’s clinical pharmacological units (CPUs) dedicated itself to respond to these challenges for nearly 40 years. All ...
  Size: 32 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Services/Early Phase I to IIa

  2010-2017 57%
  ... Reference change values to assess changes in concentrations of biomarkers of exposure in individuals participating in a cigarette-switching study. Clinical Chemistry and Laboratory Medicine ... Haefeli WE, Mikus G. Reduced exposure variability of the CYP3A substrate simvastatin by dose individualization to CYP3A activity. J Clin Pharmacol. 2013 Nov;53-(11):1199-204.  doi: ...
  Size: 65 K - Created: 09-11-15 - Modified: 27-07-17 10:05
Path: /Expertise/Published Expertise/2010-2017

  1990 – 1999 48%
  ... Formulierung von Thyroxin und Iodid: Thyreocomb N. Therapiewoche 1996 ; 46(3). Timmer W, Kleist P, Ripke H. Lücker PW, Fuder H. Intra- and interindividual response to multiple dose treatment with four lansoprazole dosage regimen and a reference treatment with omeprazole. Poster, 6 th Annual ...
  Size: 61 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Expertise/Published Expertise/1990 – 1999

FooterEnd